MedTrace Logo

Role-Playing Method in Epilepsy Teaching Among Nursing Students

NCT07667075 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2026-06-24

No results posted yet for this study

Summary

This study aims to evaluate the effects of a role-playing method in epilepsy teaching on nurse-patient communication skills, self-efficacy, and knowledge among undergraduate nursing students in Hainan Province, China. Participants will be undergraduate nursing students who meet the eligibility criteria. They will be assigned to either an intervention group or a control group. The intervention group will receive epilepsy teaching using the role-playing method, while the control group will receive conventional teaching. The outcomes will include nurse-patient communication skills, self-efficacy, and epilepsy-related knowledge. The findings of this study may provide evidence for improving nursing education methods and enhancing undergraduate nursing students' learning outcomes.

Conditions

Interventions

BEHAVIORAL

Role-Playing Method in Epilepsy Teaching

The intervention consists of epilepsy teaching delivered through structured role-playing activities. Students will participate in simulated nurse-patient communication scenarios related to epilepsy care, including seizure recognition, nursing response, patient education, and communication with patients and family members.

BEHAVIORAL

Lecture-Based Epilepsy Teaching

The control group will receive conventional lecture-based teaching on epilepsy care. The teaching will focus on epilepsy-related knowledge and nursing care content through regular classroom instruction.

Sponsors & Collaborators

  • Universiti Teknologi Malaysia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-01
Primary Completion
2024-01-20
Completion
2024-02-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07667075 on ClinicalTrials.gov